Full Press Release Details
NEW BRUNSWICK, N.J. , May 29, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12 , at the Terranea Resort in Rancho Palos Verdes, California. Tom Cavanaugh, President, Oncology, Janssen Pharmaceuticals and Scott White , President, Immunology will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
SOURCE Johnson & Johnson